{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:36:55Z","timestamp":1792517815785,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41585-025-01030-w","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:06:01Z","timestamp":1746169561000},"page":"632-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Towards precision medicine in clinical trials for the treatment of urologic chronic pelvic pain syndrome: lessons from the MAPP Research Network"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-0796","authenticated-orcid":false,"given":"Alisa J.","family":"Stephens Shields","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Quentin","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel A.","family":"Pontari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Henry","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Moldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7402-5476","authenticated-orcid":false,"given":"Catherine S.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-5157","authenticated-orcid":false,"given":"John T.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8099-0988","authenticated-orcid":false,"given":"J. Richard","family":"Landis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Naliboff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-6258","authenticated-orcid":false,"given":"Claire C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-7818","authenticated-orcid":false,"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.urology.2021.05.042","volume":"156","author":"P Jones","year":"2021","unstructured":"Jones, P. et al. Current status of intravesical therapies for bladder pain syndrome (BPS): a narrative review of emerging evidence. Urology 156, e48\u2013e57 (2021).","journal-title":"Urology"},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","volume":"193","author":"JC Nickel","year":"2015","unstructured":"Nickel, J. C. et al. Pentosan polysulfate sodium for treatment of interstitial cystitis\/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J. Urol. 193, 857\u2013862 (2015).","journal-title":"J. Urol."},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0090-4295(97)00181-7","volume":"5","author":"J Parkin","year":"1997","unstructured":"Parkin, J., Shea, C. & Sant, G. R. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis-a practical approach. Urology 5, 105\u2013107 (1997).","journal-title":"Urology"},{"key":"1030_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.juro.2016.03.003","volume":"196","author":"JC Nickel","year":"2016","unstructured":"Nickel, J. C. et al. A phase II study of the efficacy and safety of the novel oral SHIP1 activator AQX-1125 in subjects with moderate to severe interstitial cystitis\/bladder pain syndrome. J. Urol. 196, 747\u2013754 (2016).","journal-title":"J. Urol."},{"key":"1030_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/JU.0000000000000192","volume":"202","author":"JC Nickel","year":"2019","unstructured":"Nickel, J. C. et al. Targeting the SHIP1 pathway fails to show treatment benefit in interstitial cystitis\/bladder pain syndrome: lessons learned from evaluating potentially effective therapies in this enigmatic syndrome. J. Urol. 202, 301\u2013308 (2019).","journal-title":"J. Urol."},{"key":"1030_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.juro.2014.10.086","volume":"193","author":"JN Krieger","year":"2015","unstructured":"Krieger, J. N. et al. Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study. J. Urol. 193, 1254\u20131262 (2015).","journal-title":"J. Urol."},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/JU.0000000000003394","volume":"209","author":"AJ Stephens-Shields","year":"2023","unstructured":"Stephens-Shields, A. J. et al. Clinically important differences for pain and urinary symptoms in urological chronic pelvic pain syndrome: a MAPP network study. J. Urol. 209, 1132 (2023).","journal-title":"J. Urol."},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","volume":"170","author":"GR Sant","year":"2003","unstructured":"Sant, G. R. et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 170, 810\u2013815 (2003).","journal-title":"J. Urol."},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/01.ju.0000152337.82806.e8","volume":"173","author":"R Mayer","year":"2005","unstructured":"Mayer, R. et al. A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis. J. Urol. 173, 1186\u20131191 (2005).","journal-title":"J. Urol."},{"key":"1030_CR10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.juro.2009.12.106","volume":"183","author":"HE Foster","year":"2010","unstructured":"Foster, H. E. et al. Effect of amitriptyline on symptoms in treatment na\u00efve patients with interstitial cystitis\/painful bladder syndrome. J. Urol. 183, 1853\u20131858 (2010).","journal-title":"J. Urol."},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/j.pain.0000000000003455","volume":"166","author":"JT Farrar","year":"2025","unstructured":"Farrar, J. T. et al. Widespread pain phenotypes impact treatment efficacy in randomized clinical trials interstitial cystitis\/bladder an syndrome: a multidisciplinary approach to the study of Chronic Pelvic Pain network study. Pain 166, 1179\u20131190 (2025).","journal-title":"Pain"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brs.2008.03.007","volume":"1","author":"J-P Nguyen","year":"2008","unstructured":"Nguyen, J.-P. et al. Treatment of chronic neuropathic pain by motor cortex stimulation: results of a bicentric controlled crossover trial. Brain Stimulation 1, 89\u201396 (2008).","journal-title":"Brain Stimulation"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0022-3999(97)00215-8","volume":"44","author":"CC Engel","year":"1998","unstructured":"Engel, C. C., Walker, E. A., Engel, A. L., Bullis, J. & Armstrong, A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J. Psychosom. Res. 44, 203\u2013207 (1998).","journal-title":"J. Psychosom. Res."},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/STROKEAHA.116.015342","volume":"48","author":"M Rosenblum","year":"2017","unstructured":"Rosenblum, M. & Hanley, D. F. Adaptive enrichment designs for stroke clinical trials. Stroke 48, 2021\u20132025 (2017).","journal-title":"Stroke"},{"key":"1030_CR15","doi-asserted-by":"publisher","first-page":"v683","DOI":"10.1093\/annonc\/mdz283","volume":"30","author":"RL Jones","year":"2019","unstructured":"Jones, R. L. et al. 1667O \u2014 results of the TAPPAS trial: an adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS). Ann. Oncol. 30, v683 (2019).","journal-title":"Ann. Oncol."},{"key":"1030_CR16","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1093\/pm\/pnad005","volume":"24","author":"AL Hassett","year":"2023","unstructured":"Hassett, A. L. et al. An interventional response phenotyping study in chronic low back pain: protocol for a mechanistic randomized controlled trial. Pain Med. 24, S126\u2013S138 (2023).","journal-title":"Pain Med."},{"key":"1030_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-14-57","volume":"14","author":"JQ Clemens","year":"2014","unstructured":"Clemens, J. Q. et al. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol. 14, 57 (2014).","journal-title":"BMC Urol."},{"key":"1030_CR18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/nau.24423","volume":"39","author":"JQ Clemens","year":"2020","unstructured":"Clemens, J. Q. et al. The multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network*: design and implementation of the symptom patterns study (SPS). Neurourol. Urodyn. 39, 1803\u20131814 (2020).","journal-title":"Neurourol. Urodyn."},{"key":"1030_CR19","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.juro.2014.11.016","volume":"193","author":"JQ Clemens","year":"2015","unstructured":"Clemens, J. Q. et al. Comparison of baseline urological symptoms in men and women in the MAPP research cohort. J. Urol. 193, 1554\u20131558 (2015).","journal-title":"J. Urol."},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/nau.25648","volume":"44","author":"BD Naliboff","year":"2025","unstructured":"Naliboff, B. D. et al. Relationship of sex and diagnosis with symptoms and illness impact in urologic chronic pelvic pain; a MAPP network analysis. Neurourol. Urodyn. 44, 400\u2013408 (2025).","journal-title":"Neurourol. Urodyn."},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.juro.2017.05.065","volume":"198","author":"BD Naliboff","year":"2017","unstructured":"Naliboff, B. D. et al. Clinical and psychosocial predictors of urological chronic pelvic pain symptom change in 1 year: a prospective study from the MAPP research network. J. Urol. 198, 848\u2013857 (2017).","journal-title":"J. Urol."},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.juro.2015.05.105","volume":"194","author":"HH Lai","year":"2015","unstructured":"Lai, H. H. et al. Painful bladder filling and painful urgency are distinct characteristics in men and women with urological chronic pelvic pain syndromes: a MAPP research network study. J. Urol. 194, 1634\u20131641 (2015).","journal-title":"J. Urol."},{"key":"1030_CR23","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.juro.2009.12.103","volume":"183","author":"SH Berry","year":"2010","unstructured":"Berry, S. H. et al. Development, validation and testing of an epidemiological case definition of interstitial cystitis\/painful bladder syndrome. J. Urol. 183, 1848\u20131852 (2010).","journal-title":"J. Urol."},{"key":"1030_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0090-4295(99)80334-3","volume":"49","author":"LJ Simon","year":"1997","unstructured":"Simon, L. J., Landis, J. R., Erickson, D. R. & Nyberg, L. M. The interstitial cystitis data base study: concepts and preliminary baseline descriptive statistics. Urology 49, 64\u201375 (1997).","journal-title":"Urology"},{"key":"1030_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0022-5347(05)64686-1","volume":"168","author":"AJ Schaeffer","year":"2002","unstructured":"Schaeffer, A. J. et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J. Urol. 168, 593\u2013598 (2002).","journal-title":"J. Urol."},{"key":"1030_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.juro.2012.08.088","volume":"189","author":"AM Suskind","year":"2013","unstructured":"Suskind, A. M. et al. The prevalence and overlap of interstitial cystitis\/bladder pain syndrome and chronic prostatitis\/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J. Urol. 189, 141\u2013145 (2013).","journal-title":"J. Urol."},{"key":"1030_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.urology.2018.03.037","volume":"118","author":"MG Funaro","year":"2018","unstructured":"Funaro, M. G., King, A. N., Stern, J. N. H., Moldwin, R. M. & Bahlani, S. Endoscopic injection of low dose triamcinolone: a simple, minimally invasive, and effective therapy for interstitial cystitis with Hunner lesions. Urology 118, 25\u201329 (2018).","journal-title":"Urology"},{"key":"1030_CR28","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.juro.2012.08.013","volume":"188","author":"JH Hillelsohn","year":"2012","unstructured":"Hillelsohn, J. H. et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J. Urol. 188, 2238\u20132241 (2012).","journal-title":"J. Urol."},{"key":"1030_CR29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JU.0000000000001031","volume":"204","author":"HH Lai","year":"2020","unstructured":"Lai, H. H., Pickersgill, N. A. & Vetter, J. M. Hunner lesion phenotype in interstitial cystitis\/bladder pain syndrome: a systematic review and meta-analysis. J. Urol. 204, 518 (2020).","journal-title":"J. Urol."},{"key":"1030_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12532","volume":"16","author":"Y Homma","year":"2024","unstructured":"Homma, Y. et al. Definition change and update of clinical guidelines for interstitial cystitis and bladder pain syndrome. Low. Urin. Tract. Symptoms 16, e12532 (2024).","journal-title":"Low. Urin. Tract. Symptoms"},{"key":"1030_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jpain.2019.05.007","volume":"21","author":"A Schrepf","year":"2020","unstructured":"Schrepf, A. et al. ICD-10 codes for the study of chronic overlapping pain conditions in administrative databases. J. Pain\u00a021, 59\u201370 (2020).","journal-title":"J. Pain"},{"key":"1030_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/AJP.0000000000000769","volume":"36","author":"N Afari","year":"2020","unstructured":"Afari, N. et al. A MAPP network case-control study of urological chronic pelvic pain compared with nonurological pain conditions. Clin. J. Pain\u00a036, 8 (2020).","journal-title":"Clin. J. Pain"},{"key":"1030_CR33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/j.pain.0000000000002813","volume":"164","author":"A Schrepf","year":"2023","unstructured":"Schrepf, A. et al. Stimulated whole-blood cytokine\/chemokine responses are associated with interstitial cystitis\/bladder pain syndrome phenotypes and features of nociplastic pain: a multidisciplinary approach to the study of chronic pelvic pain research network study. Pain 164, 1148 (2023).","journal-title":"Pain"},{"key":"1030_CR34","doi-asserted-by":"publisher","first-page":"T93","DOI":"10.1016\/j.jpain.2016.06.002","volume":"17","author":"W Maixner","year":"2016","unstructured":"Maixner, W., Fillingim, R. B., Williams, D. A., Smith, S. B. & Slade, G. D. Overlapping chronic pain conditions: implications for diagnosis and classification. J. Pain\u00a017, T93\u2013T107 (2016).","journal-title":"J. Pain"},{"key":"1030_CR35","doi-asserted-by":"publisher","first-page":"568.e1","DOI":"10.1016\/j.ajog.2021.08.038","volume":"225","author":"S As-Sanie","year":"2021","unstructured":"As-Sanie, S. et al. Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain. Am. J. Obstet. Gynecol. 225, 568.e1\u2013568.e11 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1030_CR36","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/art.39051","volume":"67","author":"CM Brummett","year":"2015","unstructured":"Brummett, C. M. et al. Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty. Arthritis Rheumatol. 67, 1386\u20131394 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1030_CR37","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.juro.2012.01.123","volume":"187","author":"MP FitzGerald","year":"2012","unstructured":"FitzGerald, M. P. et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis\/painful bladder syndrome and pelvic floor tenderness. J. Urol. 187, 2113\u20132118 (2012).","journal-title":"J. Urol."},{"key":"1030_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41582-024-00966-8","volume":"20","author":"CM Kaplan","year":"2024","unstructured":"Kaplan, C. M. et al. Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms. Nat. Rev. Neurol. 20, 347\u2013363 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1030_CR39","doi-asserted-by":"publisher","first-page":"104502","DOI":"10.1016\/j.jpain.2024.02.016","volume":"25","author":"AG Summit","year":"2024","unstructured":"Summit, A. G. et al. Preliminary validation of a general factor model of chronic overlapping pain conditions. J. Pain\u00a025, 104502 (2024).","journal-title":"J. Pain"},{"key":"1030_CR40","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw, D. J. Fibromyalgia: a clinical review. JAMA 311, 1547\u20131555 (2014).","journal-title":"JAMA"},{"key":"1030_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3959(86)90026-6","volume":"24","author":"RB Margolis","year":"1986","unstructured":"Margolis, R. B., Tait, R. C. & Krause, S. J. A rating system for use with patient pain drawings. Pain 24, 57\u201365 (1986).","journal-title":"Pain"},{"key":"1030_CR42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.juro.2017.03.132","volume":"198","author":"HH Lai","year":"2017","unstructured":"Lai, H. H. et al. Characterization of whole body pain in urological chronic pelvic pain syndrome at baseline: a MAPP research network study. J. Urol. 198, 622\u2013631 (2017).","journal-title":"J. Urol."},{"key":"1030_CR43","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/1475-6773.13875","volume":"56","author":"TAG Quinlan","year":"2021","unstructured":"Quinlan, T. A. G., Roberts, A. W., Frank, J. W. & Whittington, M. D. Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use. Health Serv. Res. 56, 1233\u20131244 (2021).","journal-title":"Health Serv. Res."},{"key":"1030_CR44","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/head.14129","volume":"61","author":"MJ Barad","year":"2021","unstructured":"Barad, M. J., Sturgeon, J. A., Hong, J., Aggarwal, A. K. & Mackey, S. C. Characterization of chronic overlapping pain conditions in patients with chronic migraine: a CHOIR study. Headache 61, 872\u2013881 (2021).","journal-title":"Headache"},{"key":"1030_CR45","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/j.pain.0000000000002153","volume":"162","author":"SM Gaynor","year":"2021","unstructured":"Gaynor, S. M. et al. Phenotypic profile clustering pragmatically identifies diagnostically and mechanistically informative subgroups of chronic pain patients. Pain 162, 1528\u20131538 (2021).","journal-title":"Pain"},{"key":"1030_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40122-022-00382-0","volume":"11","author":"JM Hah","year":"2022","unstructured":"Hah, J. M. et al. Whole body pain distribution and risk factors for widespread pain among patients presenting with abdominal pain: a retrospective cohort study. Pain Ther. 11, 683\u2013699 (2022).","journal-title":"Pain Ther."},{"key":"1030_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/JU.0000000000002679","volume":"208","author":"P Gupta","year":"2022","unstructured":"Gupta, P. et al. Is pelvic floor muscle tenderness a distinct urologic chronic pelvic pain syndrome phenotype? Findings from the multidisciplinary approach to the study of chronic pelvic pain research network symptom pattern study. J. Urol. 208, 341\u2013349 (2022).","journal-title":"J. Urol."},{"key":"1030_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.urology.2018.03.021","volume":"116","author":"CC Yang","year":"2018","unstructured":"Yang, C. C., Miller, J. L., Omidpanah, A. & Krieger, J. N. Physical examination for men and women with urologic chronic pelvic pain syndrome: a MAPP (Multidisciplinary Approach to the Study of Chronic Pelvic Pain) network study. Urology 116, 23\u201329 (2018).","journal-title":"Urology"},{"key":"1030_CR49","doi-asserted-by":"publisher","first-page":"255.e1","DOI":"10.1016\/j.ajog.2018.11.1106","volume":"220","author":"MR Meister","year":"2019","unstructured":"Meister, M. R. et al. Development of a standardized, reproducible screening examination for assessment of pelvic floor myofascial pain. Am. J. Obstet. Gynecol. 220, 255.e1\u2013255.e9 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1030_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/bju.13832","volume":"120","author":"A Dagher","year":"2017","unstructured":"Dagher, A. et al. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network. BJU Int. 120, 130\u2013142 (2017).","journal-title":"BJU Int."},{"key":"1030_CR51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/JU.0000000000001391","volume":"205","author":"R Roy","year":"2021","unstructured":"Roy, R. et al. Association of longitudinal changes in symptoms and urinary biomarkers in patients with urological chronic pelvic pain syndrome: a MAPP research network study. J. Urol. 205, 514\u2013523 (2021).","journal-title":"J. Urol."},{"key":"1030_CR52","doi-asserted-by":"publisher","first-page":"F1613","DOI":"10.1152\/ajprenal.90344.2008","volume":"295","author":"R Saban","year":"2008","unstructured":"Saban, R. et al. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am. J. Physiol. Renal Physiol. 295, F1613\u2013F1623 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1030_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/s-0037-1615552","volume":"82","author":"HH Marti","year":"1999","unstructured":"Marti, H. H. & Risau, W. Angiogenesis in ischemic disease. Thromb. Haemost. 82, 44\u201352 (1999).","journal-title":"Thromb. Haemost."},{"key":"1030_CR54","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0022-5347(05)68552-7","volume":"162","author":"MA Pontari","year":"1999","unstructured":"Pontari, M. A., Hanno, P. M. & Ruggieri, M. R. Comparison of bladder blood flow in patients with and without interstitial cystitis. J. Urol. 162, 330\u2013334 (1999).","journal-title":"J. Urol."},{"key":"1030_CR55","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.4049\/jimmunol.1401528","volume":"193","author":"M Steigedal","year":"2014","unstructured":"Steigedal, M. et al. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J. Immunol. 193, 6081\u20136089 (2014).","journal-title":"J. Immunol."},{"key":"1030_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.juro.2015.01.037","volume":"194","author":"JC Nickel","year":"2015","unstructured":"Nickel, J. C. et al. Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP research network. J. Urol. 194, 127\u2013135 (2015).","journal-title":"J. Urol."},{"key":"1030_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/jcm8030415","volume":"8","author":"JC Nickel","year":"2019","unstructured":"Nickel, J. C. et al. A culture-independent analysis of the microbiota of female interstitial cystitis\/bladder pain syndrome participants in the MAPP research network. J. Clin. Med. 8, 415 (2019).","journal-title":"J. Clin. Med."},{"key":"1030_CR58","doi-asserted-by":"crossref","unstructured":"Kelly, W. K. & Halabi, S. Oncology Clinical Trials: Successful Design, Conduct, and Analysis (Springer, 2018).","DOI":"10.1891\/9780826168733"},{"key":"1030_CR59","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/bjc.2012.84","volume":"106","author":"P Silcocks","year":"2012","unstructured":"Silcocks, P. How many strata in an RCT? A flexible approach. Br. J. Cancer 106, 1259\u20131261 (2012).","journal-title":"Br. J. Cancer"},{"key":"1030_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/AJP.0b013e318208c8e4","volume":"27","author":"EM O\u2019Brien","year":"2011","unstructured":"O\u2019Brien, E. M. et al. Intraindividual variability in daily sleep and pain ratings among chronic pain patients: bidirectional association and the role of negative mood. Clin. J. Pain\u00a027, 425 (2011).","journal-title":"Clin. J. Pain"},{"key":"1030_CR61","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/art.21407","volume":"52","author":"RE Harris","year":"2005","unstructured":"Harris, R. E. et al. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 52, 3670\u20133674 (2005).","journal-title":"Arthritis Rheum."},{"key":"1030_CR62","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/sim.4780071114","volume":"7","author":"SJ Senn","year":"1988","unstructured":"Senn, S. J. How much of the placebo \u2018effect\u2019 is really statistical regression? Stat. Med. 7, 1203 (1988).","journal-title":"Stat. Med."},{"key":"1030_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/15265160903098283","volume":"9","author":"S Senn","year":"2009","unstructured":"Senn, S. Placebo misconceptions. Am. J. Bioeth. 9, 53\u201354 (2009).","journal-title":"Am. J. Bioeth."},{"key":"1030_CR64","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1093\/rheumatology\/keq245","volume":"49","author":"M Artus","year":"2010","unstructured":"Artus, M., van der Windt, D. A., Jordan, K. P. & Hay, E. M. Low back pain symptoms show a similar pattern of improvement following a wide range of primary care treatments: a systematic review of randomized clinical trials. Rheumatology 49, 2346\u20132356 (2010).","journal-title":"Rheumatology"},{"key":"1030_CR65","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.pain.2014.05.009","volume":"155","author":"JT Farrar","year":"2014","unstructured":"Farrar, J. T. et al. Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION study. Pain 155, 1622\u20131631 (2014).","journal-title":"Pain"},{"key":"1030_CR66","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.juro.2016.04.070","volume":"196","author":"AJ Stephens-Shields","year":"2016","unstructured":"Stephens-Shields, A. J. et al. Symptom variability and early symptom regression in the MAPP study: a prospective study of urological chronic pelvic pain syndrome. J. Urol. 196, 1450\u20131455 (2016).","journal-title":"J. Urol."},{"key":"1030_CR67","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/JU.0000000000002438","volume":"207","author":"BD Naliboff","year":"2022","unstructured":"Naliboff, B. D. et al. Reliability and validity of pain and urinary symptom severity assessment in urologic chronic pelvic pain; a MAPP network analysis. J. Urol. 207, 1246\u20131255 (2022).","journal-title":"J. Urol."},{"key":"1030_CR68","unstructured":"Schrepf, A. et al. Widespread pain moderates the response to the centrally-acting therapies in an observational cohort of patients with urologic chronic pelvic pain syndrome: a MAPP Research Network study. Neurourol. Urodyn. (in the press)."},{"key":"1030_CR69","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.urology.2023.05.047","volume":"180","author":"G Pattabiraman","year":"2023","unstructured":"Pattabiraman, G. et al. Efficacy of targeted mast cell inhibition therapy in chronic prostatitis\/chronic pelvic pain syndrome. Urology 180, 200\u2013208 (2023).","journal-title":"Urology"},{"key":"1030_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2007.02.067","volume":"70","author":"KM Peters","year":"2007","unstructured":"Peters, K. M., Carrico, D. J., Kalinowski, S. E., Ibrahim, I. A. & Diokno, A. C. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 70, 16\u201318 (2007).","journal-title":"Urology"},{"key":"1030_CR71","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.juro.2015.11.012","volume":"195","author":"JW Griffith","year":"2016","unstructured":"Griffith, J. W. et al. Pain and urinary symptoms should not be combined into a single score: psychometric findings from the MAPP research network. J. Urol. 195, 949\u2013954 (2016).","journal-title":"J. Urol."},{"key":"1030_CR72","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","volume":"310","author":"JM Bland","year":"1995","unstructured":"Bland, J. M. & Altman, D. G. Multiple significance tests: the Bonferroni method. BMJ 310, 170 (1995).","journal-title":"BMJ"},{"key":"1030_CR73","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","volume":"75","author":"Y HOCHBERG","year":"1988","unstructured":"HOCHBERG, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75, 800\u2013802 (1988).","journal-title":"Biometrika"},{"key":"1030_CR74","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65\u201370 (1979).","journal-title":"Scand. J. Stat."},{"key":"1030_CR75","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1056\/NEJMra1709701","volume":"378","author":"A Dmitrienko","year":"2018","unstructured":"Dmitrienko, A. & D\u2019Agostino, R. B. Multiplicity considerations in clinical trials. N. Engl. J. Med. 378, 2115\u20132122 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1030_CR76","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1097\/j.pain.0000000000001324","volume":"159","author":"KV Patel","year":"2018","unstructured":"Patel, K. V. et al. Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis. Pain 159, 2245 (2018).","journal-title":"Pain"},{"key":"1030_CR77","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"DT Felson","year":"1993","unstructured":"Felson, D. T. et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 36, 729\u2013740 (1993).","journal-title":"Arthritis Rheum."},{"key":"1030_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01431-y","volume":"21","author":"KF Rabe","year":"2020","unstructured":"Rabe, K. F. et al. Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial. Respir. Res. 21, 177 (2020).","journal-title":"Respir. Res."},{"key":"1030_CR79","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/cid\/civ495","volume":"61","author":"SR Evans","year":"2015","unstructured":"Evans, S. R. et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin. Infect. Dis. 61, 800\u2013806 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"1030_CR80","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/jnnp-2021-328194","volume":"93","author":"RPA van Eijk","year":"2022","unstructured":"van Eijk, R. P. A., van den Berg, L. H. & Lu, Y. Composite endpoint for ALS clinical trials based on patient preference: patient-ranked order of function (PROOF). J. Neurol. Neurosurg. Psychiatry 93, 539\u2013546 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1030_CR81","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.amepre.2007.01.022","volume":"32","author":"LM Collins","year":"2007","unstructured":"Collins, L. M., Murphy, S. A. & Strecher, V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent ehealth interventions. Am. J. Prev. Med. 32, S112\u2013S118 (2007).","journal-title":"Am. J. Prev. Med."},{"key":"1030_CR82","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/biostatistics\/kxt010","volume":"14","author":"N Simon","year":"2013","unstructured":"Simon, N. & Simon, R. Adaptive enrichment designs for clinical trials. Biostatistics 14, 613\u2013625 (2013).","journal-title":"Biostatistics"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01030-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:35:56Z","timestamp":1757169356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01030-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01030-w","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"27 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.S. reports consulting fees from Gilead Sciences and grant funding from Argenx. R.M. reports grant funding and consulting fees from Ironwood Pharmaceuticals, grant funding from Vaneltix and consulting fees from Glycologix. J.T.F. reports over the past 3 years funding from NIH-NCATS \u2014 UL1 Grant (Co-I), NIH-NIDDK \u2014 U01 Grants (Co-I), from NIH-NINDS \u2014 U24 Grant (PI) and two FDA-BAA Contracts; and compensation for serving on two NIH DSMBs and consulting from Vertex Pharma and EicOsis Pharma. J.T.F. serves as the current president of the United States Association for the Study of Pain, and D.A.W. reports service as a consultant to Community Health Focus, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}